Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review

BACKGROUND: We identified anti-obesity medications withdrawn since 1950 because of adverse drug reactions after regulatory approval, and examined the evidence used to support such withdrawals, investigated the mechanisms of the adverse reactions, and explored the trends over time. METHODS: We conduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Onakpoya, Igho J., Heneghan, Carl J., Aronson, Jeffrey K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126837/
https://www.ncbi.nlm.nih.gov/pubmed/27894343
http://dx.doi.org/10.1186/s12916-016-0735-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126837/
https://www.ncbi.nlm.nih.gov/pubmed/27894343
http://dx.doi.org/10.1186/s12916-016-0735-y

Ejemplares similares